RCM - R1 RCM Inc Kapitalizatsiyaning prognoz qilingan daromadga nisbati

R1 RCM Inc. (RCM) tovar belgisi

R1 RCM Inc. murakkab dasturiy ta'minot integratsiyasi orqali shartlarni belgilab, klinikalarning daromadlar siklini boshqarish sohasida ustunlikka ega. GURU.Markets platformasidagi kelajakdagi EV/Revenue grafigi baholash tendentsiyasini aks ettiradi, bunda oxirgi ko'rsatkich 2.40 darajasida turibdi. AI asosidagi hisob-kitob avtomatlashtirish yechimlari ushbu o'sishni qo'llab-quvvatlamoqda, rahbariyat esa kompaniyani xususiy biznes maqomiga muvaffaqiyatli moslashtirish orqali barqarorlikni ta'minlamoqda.

RCM (R1 RCM Inc.) Forvard narx/daromad multiplikatori tarixi 04.07.2022dan 30.11.2024gacha

r1rcm.com (RCM) kompaniyasi koʻrsatkichlari kesimi va tahlili

- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi statistikasi:
Kompaniyaning jamlanma tahliliyoti:R1 RCM Inc (RCM)
R1 RCM, Inc. asosiy tovari

Forward P/S kompaniyaning bozor qiymatini kutilayotgan daromadga nisbatan o'lchaydi, bu esa kelajakdagi o'sish sur'atlari va biznes marjalari uchun to'langan premiumni baholash imkonini beradi. Forward P/S ko'paytiruvchisini tahlil qilish orqali investor R1 RCM Inc. (RCM) kompaniyasining kapitalizatsiya barqarorligini aniqlaydi va bunda ularning dasturiy ta'minotining AQSh ning yirik klinikalarining pul oqimlari uchun o'ta muhimligi hamda tarmoqning operatsion daromadlari barqarorligiga tayanadi.

R1 RCM Inc. raqobatchilari

Kapitalizatsiyaning kutilayotgan sotuvga nisbati VEEV|Doximity Inc - Narxning prognoz qilingan daromadga nisbati|HealthEquity Corp (HQY) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|WAY - Forvard P/S multiplikatori|CRVL (CorVel Corporation) - Forvard narx/daromad multiplikatori|Forvard narx/daromad multiplikatori priviahealth.com|HURN: Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CERT|Omnicell Corp (OMCL) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori GoodRx Gold (GDRX)|Schrodinger, Inc. - Forvard narx/daromad multiplikatori|phreesia.com - Narxning prognoz qilingan daromadga nisbati|OMDA: Forvard narx/daromad multiplikatori|EVH - Forvard P/S multiplikatori|HealthStream Corp - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori Definitive Corp|Consensus Cloud Solutions (CCSI) - Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori agilonhealth.com (AGL)|Absci Corporation (ABSI) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SY (So-Young International Inc)|National Research Corporation - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori USA Mobility SPOK|OPRX (OptimizeRx Corporation) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TBRG - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Simulations Plus|SOPH (SOPHiA GENETICS) - Narxning prognoz qilingan daromadga nisbati|HCAT - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CareCloud Corp|Forvard narx/daromad multiplikatori RSSS (Research Solutions)|DLHC (dlhcorp.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati OneMedNet ONMD|Sotuvga nisbatan forvard narx SCNX|Healthcare Triangle Corp - Forvard P/S multiplikatori|iSpecimen Inc. (ISPC) - Forvard narx/daromad multiplikatori|bullfrogai.com (BFRG) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori scworx.com|Forvard narx/daromad multiplikatori MSPR|ICCT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori MEDS|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Orgenesis Corporation|Narxning prognoz qilingan daromadga nisbati Sharecare, Inc. SHCR|STRM: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Syra Health - Forvard P/S multiplikatori|Apollo Medical Holdings (AMEH) - Forvard narx/daromad multiplikatori|MODN (Model N Corp) - Forvard narx/daromad multiplikatori|NXGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati